Cancer clinical trials in the region Pays de la Loire
199 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT06552234
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
None
1
2
3 or more
6 main criterias to confirm
CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase 2
Breast cancer
#NCT04862663
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Targeted therapy
5 main criterias to confirm
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
AstraZeneca
Phase 2
Lung cancer
#NCT04884282
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Other mutation
Immunotherapy
Chemotherapy
1
ALK
EGFR
ROS-1
Systemic Treatment-Naive
8 main criterias to confirm
Centre Hospitalier de Cholet (Cholet)
Fondazione Ricerca Traslazionale
Phase 2
Breast cancer
#NCT04561362
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
6 main criterias to confirm
Centre Eugene Marquis (Rennes)
BicycleTx Limited
Phase 2
Lung cancer
#NCT04561362
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Other mutation
ALK
EGFR
ROS-1
Systemic Treatment-Naive
6 main criterias to confirm
Centre Eugene Marquis (Rennes)
BicycleTx Limited
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05118789
SCLC (Small Cell Lung Cancer)
Mesothelium
Locally Advanced
Metastatic
Metastatic Castration-resistant
ROS-1
1
Systemic Treatment-Naive
6 main criterias to confirm
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes)
Nuvalent Inc.
Phase 2
Breast cancer
#NCT06247995
HER2 Negative
HR Positive
Metastatic
Targeted therapy
Hormone therapy
1
2
3 or more
Chemotherapy
7 main criterias to confirm
Centre Hospitalier Universitaire Laennec (Saint-Herblain)
Novartis
Phase 2
Breast cancer
#NCT06078384
HER2 Negative
HR Negative
Localized
Surgery
Systemic Treatment-Naive
Immunotherapy
7 main criterias to confirm
Centre Eugene Marquis (Rennes)
UNICANCER
Phase 2
Breast cancer
#NCT05955170
HER2 Positive
Metastatic
Chemotherapy
Targeted therapy
Chemotherapy
Targeted therapy
1
6 main criterias to confirm
Hôpital Privé du Confluent - Vivalto Santé (Nantes)
Institut Curie
Phase 2
Lung cancer
#NCT05856695
SCLC (Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
None
5 main criterias to confirm
Centre Hospitalier de Cholet (Cholet), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier du Mans (Le Mans), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Régional Universitaire de Tours (Tours)
Intergroupe Francophone de Cancérologie Thoracique